← Open Payments lookup

PARTHSARTHI PATEL: Open Payments

NPI 1629171756 · NEWINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,938 in 167 payments from 26 companies in 2025. Trend: 2023 $2,857 · 2024 $2,897 · 2025 $2,938

Food & beverage: $2,938
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP22$571
ABBVIE INC.35$531
GlaxoSmithKline, LLC.14$202
Bayer Healthcare Pharmaceuticals Inc.18$189
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$171
Esperion Therapeutics, Inc.11$151
Lilly USA, LLC5$134
Vanda Pharmaceuticals Inc.4$116
PFIZER INC.5$103
Indivior Inc.3$88

Products named: BREZTRI, TRELEGY ELLIPTA, VRAYLAR, Kerendia, CAPLYTA, QULIPTA, NEXLETOL, HETLIOZ.

Industry payments across CT — which companies pay providers there.